EBOS Group Limited
ASX:EBO Lagerbericht
Marktkapitalisierung: AU$6.6b
EBOS Group Ausschüttungen und Rückkäufe
Zukünftiges Wachstum Kriterienprüfungen 4/6 EBOS Group ist ein dividendenzahlendes Unternehmen mit einer aktuellen Rendite von 3.33%, die durch die Erträge gut gedeckt ist.
Wichtige Informationen
3.3%
Dividendenausschüttung
Gesamte Aktionärsrendite 3.3% Zukünftige Dividendenrendite 3.6% Wachstum der Dividende -3.0% Nächster Dividendenzahlungstermin n/a Ex-Dividendendatum n/a Dividende pro Aktie AU$1.246 Ausschüttungsquote 78%
Jüngste Updates zu Dividenden und Rückkäufen
EBOS Group Limited Announces Final Dividend, Payable on 18 September 2024 Aug 23
EBOS Group Limited Announces Fully Franked Ordinary Dividend for the Six Months Ended June 30, 2023, Payable on 29 September, 2023 Sep 27
Upcoming dividend of NZ$0.60 per share at 3.0% yield Aug 31 Ebos Group Limited Announces Dividend, Payable on 29 September 2023
Upcoming dividend of NZ$0.51 per share Sep 01
EBOS Group Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 30 September, 2022 Aug 24
Alle Updates anzeigen EBOS Group Limited Announces the Retirement of Peter Williams as Director
Final dividend of NZ$0.64 announced Aug 23
EBOS Group Limited Announces Final Dividend, Payable on 18 September 2024 Aug 23
Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Aug 21
EBOS Group Limited Announces Chief Financial Officer Changes Apr 27
Insider recently sold AU$4.9m worth of stock Mar 08
First half dividend of NZ$0.60 announced Feb 25
First half 2024 earnings released: EPS: AU$0.71 (vs AU$0.70 in 1H 2023) Feb 22 EBOS Group Limited to Report Fiscal Year 2024 Results on Aug 21, 2024
Now 20% undervalued Feb 02
EBOS Group Limited to Report First Half, 2024 Results on Feb 21, 2024 Jan 10
EBOS Group Limited (NZSE:EBO) acquired additional 39% stake in Transmedic Pte Ltd. from TS Lee for approximately SGD 120 million. Dec 20
Paragon Care Reportedly Taps Rothschild for Defence Amid Buyout Talk Dec 15
EBOS Reportedly Runs Eye over Paragon Care after Abandoning Greencross Pursuit Dec 07
EBOS Not to Proceed with Acquisition in Animal Care Segment Nov 24
EBOS Not to Proceed with Acquisition in Animal Care Segment Nov 23
Now 21% undervalued Nov 13
EBOS Group Limited Announces Fully Franked Ordinary Dividend for the Six Months Ended June 30, 2023, Payable on 29 September, 2023 Sep 27
Now 21% undervalued Sep 05
Upcoming dividend of NZ$0.60 per share at 3.0% yield Aug 31 Ebos Group Limited Announces Dividend, Payable on 29 September 2023
Full year 2023 earnings: Revenues and EPS in line with analyst expectations Aug 23
Investor sentiment deteriorates as stock falls 17% Jun 07
Now 26% undervalued after recent price drop Jun 06
First half 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Feb 22 EBOS Group Limited to Report Q2, 2023 Results on Feb 22, 2023
EBOS Group Limited Announces the Appointment of Mark Bloom as an Independent Director, Effective 16 September 2022 Sep 15
Upcoming dividend of NZ$0.51 per share Sep 01
Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Aug 24
EBOS Group Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 30 September, 2022 Aug 24
Upcoming dividend of NZ$0.49 per share Feb 24
First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Feb 18 EBOS Group Limited Announces Fully Franked Ordinary Dividend for the Six Months Ended December 31, 2021, Payable on March 18, 2022
Ebos Group Limited Announces Resignation of Nick Dowling as Director Feb 08
Independent Director recently bought AU$55k worth of stock Dec 19
Price target increased to AU$31.66 Nov 03
EBOS Group Limited Announces Supplementary Dividend for the Six Months Ended June 30, 2021, Payable on Sept. 24, 2021 Sep 24
Upcoming dividend of NZ$0.48 per share Sep 02
EBOS Group Limited (EBOS) acquired Sentry Medical. Sep 01
Full year 2021 earnings released: EPS AU$1.13 (vs AU$1.01 in FY 2020) Aug 23
EBOS Group Limited (NZSE:EBO) acquired Pioneer Medical Limited for AUD 40 million. Aug 18
Price target raised to AU$25.70 Feb 20
First half 2021 earnings released: EPS AU$0.57 (vs AU$0.51 in 1H 2020) Feb 19
Revenue beats expectations Feb 19
EBOS Group Limited (NZSE:EBO) acquired Vet Distribution Business of Clifford Hallam Healthcare Pty Ltd for AUD 9.2 million. Feb 18 EBOS Group Limited (NZSE:EBO) acquired CH2 Vet for AUD 9.2 million.
EBOS Group Limited, Annual General Meeting, Oct 19, 2021 Feb 01
New 90-day high: AU$27.92 Jan 04
New 90-day high: AU$25.25 Dec 15
EBOS Group Limited (NZSE:EBO) entered into an agreement to acquire Cryomed Aesthetics Pty Limited for AUD 14.1 million. Oct 13
New 90-day high: AU$23.26 Oct 13
New 90-day high - AU$21.38 Sep 01
Full year earnings released - EPS AU$1.01 Aug 21
New 90-day low - AU$20.00 Aug 13
Stabilität und Wachstum des Zahlungsverkehrs
Stabile Dividende: EBODie Dividende je Aktie war in den letzten 10 Jahren stabil.
Wachsende Dividende: EBODie Dividendenzahlungen des Unternehmens sind in den letzten 10 Jahren gestiegen.
Dividendenrendite im Vergleich zum Markt EBOS Group Dividendenrendite im Vergleich zum Markt
Wie sieht die Dividendenrendite von EBO im Vergleich zum Markt aus? Segment Dividendenrendite Unternehmen (EBO) 3.3% Untere 25 % des Marktes (AU) 2.6% Markt Top 25 % (AU) 6.1% Branchendurchschnitt (Healthcare) 2.7% Analystenprognose (EBO) (bis zu 3 Jahre) 3.6%
Bemerkenswerte Dividende: EBODie Dividende des Unternehmens (3.33%) ist höher als die der untersten 25% der Dividendenzahler auf dem Australian Markt (2.58%).
Hohe Dividende: EBODie Dividende des Unternehmens (3.33%) ist im Vergleich zu den besten 25% der Dividendenzahler auf dem Markt Australian (6.12%) niedrig.
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: Bei der derzeitigen Ausschüttungsquote (78.2%) sind die Zahlungen von EBO durch die Erträge gedeckt.
Barausschüttung an die Aktionäre
Cashflow-Deckung: Mit seiner hohen Ausschüttungsquote (96.4%) sind die Dividendenzahlungen von EBO nicht ausreichend durch den Cashflow gedeckt.
Entdecken Sie dividendenstarke Unternehmen Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}